Therefore, ambulatory SCN5A DCM patients considered for class IC AAD should first undergo sodium channel blocker challenge testing with ajmaline preferably in a center of expertise with BrS [47]. The gene discussed is SCN5A; the disease is familial dilated cardiomyopathy.